Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

SPECIAL HEALTH RESOURCES FOR TEXAS, INC.

NPI: 1942665112 · TEXARKANA, AR 71854 · Federally Qualified Health Center (FQHC) · NPI assigned 12/15/2015

$3.87M
Total Medicaid Paid
59,911
Total Claims
43,560
Beneficiaries
47
Codes Billed
2018-12
First Month
2024-12
Last Month

Provider Details

Authorized OfficialNESVIG, KIM (CEO)
Parent OrganizationSPECIAL HEALTH RESOURCES FOR TEXAS, INC.
NPI Enumeration Date12/15/2015

Related Entities

Other providers sharing the same authorized official: NESVIG, KIM

ProviderCityStateTotal Paid
SPECIAL HEALTH RESOURCES FOR TEXAS, INCORPORATED PARIS TX $19.54M
SPECIAL HEALTH RESOURCES FOR TEXAS, INC LONGVIEW TX $15.07M
SPECIAL HEALTH RESOURCES FOR TEXAS, INC. LONGVIEW TX $519K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 25 $3K
2019 9,081 $491K
2020 9,024 $520K
2021 21,748 $1.49M
2022 13,777 $848K
2023 4,907 $348K
2024 1,349 $172K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
T1015 Clinic visit/encounter, all-inclusive 19,280 16,481 $3.22M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 3,748 3,427 $144K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 2,519 2,104 $129K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 2,615 2,092 $126K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 2,099 1,738 $114K
D0999 Unspecified diagnostic procedure, by report 648 470 $38K
90460 Immunization administration through 18 years of age via any route, first or only component 12,860 4,188 $19K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 379 370 $18K
99383 344 253 $13K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 184 170 $12K
99381 208 161 $9K
99382 231 179 $9K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 236 229 $9K
90461 4,175 2,869 $6K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 256 240 $4K
D0120 Periodic oral evaluation - established patient 170 131 $2K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 55 55 $2K
D1120 Prophylaxis - child 109 76 $1K
D1206 Topical application of fluoride varnish 146 114 $1K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 43 41 $463.92
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 46 44 $375.30
D0272 Bitewings - two radiographic images 12 12 $222.30
D0603 160 137 $200.03
90710 725 638 $126.64
90633 754 644 $103.94
90670 1,914 1,598 $100.36
D0274 Bitewings - four radiographic images 27 16 $98.80
96110 Developmental screening, with scoring and documentation, per standardized instrument 17 15 $79.20
90686 724 635 $41.84
90696 185 167 $39.42
90715 160 139 $32.26
90734 158 139 $13.14
90658 33 31 $9.56
36415 Collection of venous blood by venipuncture 79 75 $5.25
90723 1,443 1,231 $0.00
90651 57 57 $0.00
87428 38 37 $0.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 160 121 $0.00
D1330 15 13 $0.00
90688 16 14 $0.00
90680 94 94 $0.00
90474 51 51 $0.00
90681 401 327 $0.00
90648 1,855 1,557 $0.00
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 252 244 $0.00
90700 75 68 $0.00
90472 Immunization administration, each additional vaccine (list separately) 155 68 $0.00